Dr. Kasey A Huff-ignatin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1003 Reserve Blvd, Spring Hill, TN 37174 Phone: 931-380-0448 Fax: 931-486-2265 |
News Archive
New scientific evidence challenges a popular conception that behaviours such as repetitive hand-washing, characteristic of obsessive-compulsive disorder, are carried out in response to disturbing obsessive fears.
Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced the acquisition of worldwide rights to a biogeneric version of filgrastim and an affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, Croatia) (ZSE: PLVA-R-A), a move that will help extend Hospira's reach and vertical integration in biogenerics. Financial terms of the agreement were not disclosed.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
For more than five years, OHAfrica - through TÅ¡epong Clinic - has helped support HIV/AIDS treatment and testing in Lesotho, a small country in southern Africa with the third highest HIV infection rate in the world.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 5 days ago